Glaxosmithkline Pharmaceuticals Ltd Financials

Glaxosmithkline Pharmaceuticals Ltd Share Price
Detail Overview
Pharmaceuticals - MultinationalNSE
₹2,404.70
-29.00(-1.19%)
As on 23 Oct 2026 at 15:57
As of 23 Oct 2026 at 15:57, Glaxosmithkline Pharmaceuticals Ltd is trading at ₹2,404.70. The 52-week range stands at ₹2,088.10–₹3,120.70, with a market cap of ₹40.74 thousand crore. At a P/E of 38.49 and a dividend yield of 2.37%, it is a large-cap stock in the Pharmaceuticals sector.

Glaxosmithkline Pharmaceuticals Ltd Financial Statements

01,0002,0003,0004,000₹3,407FY24+9.28%₹3,723FY25+1.79%₹3,790FY26

*All values are in INR Crore

Frequently asked questions

The Glaxosmithkline Pharmaceuticals Ltd revenue for the latest reported period is ₹3,790 crore, compared with ₹3,723 crore in the previous period.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now